Removal of glucose from the cardiopulmonary bypass prime: A prospective clinical audit

Journal of Extra-Corporeal Technology

Volumn 36, Issue 3, 2004, Pages 240-244

  Newland, R F ^a   Baker, R A ^a,b   Mazzone, A L ^a   Ottens, J ^b   Sanderson, A J ^b   Moubarak, J R ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b Ashford Hospital   (United Kingdom)

Author keywords

Cardiopulmonary bypass; Clinical audit; Glucose; Mannitol

Indexed keywords

ALBUMIN; BICARBONATE; GLUCOSE; HARTMANN SOLUTION; HEART ENZYME; MANNITOL; OSMOTIC AGENT; POLYGELINE;

ADULT; AGED; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART SURGERY; HEMATOCRIT; HEMATOLOGY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MORTALITY; PEROPERATIVE CARE; PLASMA OSMOLALITY; POSTOPERATIVE CARE; PROSPECTIVE STUDY; RESPIRATORY TRACT INTUBATION; TIME;

EID: 7544228265     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Wass CT, Lanier WL. Glucose modulation of ischaemic brain injury; Review and clinical recommendations. Mayo Clin Proc. 1996;71:801-12.
2. Broderick JP, Hagen T, Brott T, Tomsick T. Hyperglycemia and hemorrhagic transformation of cerebral infarcts. Stroke. 1995;26:484-7.
3. Li PA, Siesjo BK. Role of hyperglycemia-related acidosis in ischemic brain damage. Acta Physiol Scand. 1997;161:567-80.
4. Rassias AJ, Marrin CAS, Arruda J, et al. Insulin infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth Analg. 1999;88:1011-6.
5. Mangano CM, Diamondstone LS, Ramsay JG, et al. Renal dysfunction after myocardial revascularization; Risk factors, adverse outcomes, and hospital utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194-203.
6. Jenkins IR, Curtis AP. The combination of mannitol and albumin in the priming solution reduces positive intraoperative fluid balance during cardiopulmonary bypass. Perfusion. 1995;10:301-5.
7. Fisher AR, Jones P, Barlow P, et al. The influence of mannitol on renal function during and after open-heart surgery. Perfusion. 1998;13:181-6.
8. Gustafson PA, Zarro DL, Palanzo DA, et al. Conventional approach to glucose management for diabetic patients undergoing coronary artery bypass surgery. Perfusion. 2002;17:141-4.
9. Murkin JM. The role of glucose management in adverse outcomes after CPB. The ASCVP Gazette, June. 2001;2:22-4.
10. Rao VR, Christakis GT, Weisel RD, et al. The Insulin Cardioplegia Trial: Myocardial protection for urgent coronary bypass grafting. J Thorac Cardiovasc Surg. 2002;123:928-35.
11. Utley JR. In: Cardiopulmonary Bypass: Principles and Practice. Gravlee GP, Davis RF, Utley JR. eds. Baltimore: Williams & Wilkins. 1993:502-3.
12. Read DH, Manners JM. Osmolal excretion after open-heart surgery. Anesthesia. 1983;38:1053-61.
13. Yeboah ED, Petrie A, Pead JL. Acute renal failure and open-heart surgery. Br Med J. 1972;1:415-8.
14. Christlieb IY, Clark RE. Adequacy of the perfusate: Its influence on successful myocardial protection. J Thorac Cardiovasc Surg. 1982;84:689-95.